Myelodysplastic/Myeloproliferative Neoplasm

Myelodysplastic/Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

528 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 115
Recruiting: 70
Ph III recruiting: 3
Growth YoY: —
Industry share: 16%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (77)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00324324	Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant	terminated	Phase 3	240	OHSU Knight Cancer InstituteOTHER	1	May 9, 2017	clinicaltrials
NCT01749111	Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis(CICLODECH)	terminated	Phase 3	3	Hospital Israelita Albert EinsteinOTHER	1	Mar 3, 2017